-
Soligenix Inc. (OTCBB:SNGX), Princeton, N.J. U.S. Department of Health and Human Services (HHS), Washington, D.C. Business: Other Soligenix said it submitted a full proposal to HHS's Biomedical Advanced Research and …
Published on 2/25/2013
-
University of California San Diego, La Jolla, Calif. Business: Cancer The university's Moores Cancer Center joined the Worldwide Innovative Networking (WIN) Consortium. The consortium, which includes academic …
Published on 2/25/2013
-
ViaCyte Inc., San Diego, Calif. California Institute for Regenerative Medicine (CIRM), San Francisco, Calif. Juvenile Diabetes Research Foundation International (JDRF), New York, N.Y. Business: Endocrine/Metabolic CIRM …
Published on 2/25/2013
-
Angel Biotechnology Holdings plc (LSE:ABH), Edinburgh, U.K. Business: Biomanufacturing Angel Biotechnology appointed Blair Nimmo and Gary Fraser of KPMG LLP as administrators after the termination of discussions with …
Published on 2/18/2013
-
Diamyd Medical AB (SSE:DIAM B; OTCQX:DMYDY), Stockholm, Sweden Business: Endocrine/Metabolic Diamyd said it will convene an extraordinary general meeting on March 13 to address a proposal from a group of shareholders …
Published on 2/18/2013
-
Exco InTouch Ltd., Hertfordshire, U.K. The Critical Path Institute, Tucson, Ariz. Business: Other Exco InTouch joined the institute's Electronic Patient-Reported Outcome (ePRO) Consortium to develop guidelines for using…
Published on 2/18/2013
-
General Electric Co. (NYSE:GE), Fairfield, Conn. National Institutes of Health, Bethesda, Md. Vanderbilt University, Nashville, Tenn. Business: Cancer General Electric's technology development arm, GE Global Research, …
Published on 2/18/2013
-
Genetic Technologies Ltd. (ASX:GTG; NASDAQ:GENE), Fitzroy, Australia Myriad Genetics Inc. (NASDAQ:MYGN), Salt Lake City, Utah Business: Diagnostic The Federal Court of Australia ruled on Friday that isolated genes are …
Published on 2/18/2013
-
Helmedix Pty. Ltd., Sydney, Australia Business: Autoimmune Helmedix debuted with A$1.3 million ($1.3 million) in seed funding from Australia's Medical Research Commercialization Fund (MRCF) to develop peptides to …
Published on 2/18/2013
-
Impax Laboratories Inc. (NASDAQ:IPXL), Hayward Calif. Shire plc (LSE:SHP; NASDAQ:SHPG), Dublin, Ireland Business: Neurology Shire and Impax settled litigation relating to a 2009 deal under which Shire supplies Impax …
Published on 2/18/2013
-
Innovative Medicines Initiative (IMI), Brussels, Belgium Business: Infectious The EU's Innovative Medicines Initiative said it launched two projects under its New Drugs for Bad Bugs (ND4BB) antimicrobial resistance …
Published on 2/18/2013
-
Merck & Co. Inc. (NYSE:MRK), Whitehouse Station, N.J. Business: Cardiovascular Merck said it reached an agreement in principle to settle two class action suits pending in the U.S. District Court for the District of New …
Published on 2/18/2013
-
New York University Cancer Institute, New York, N.Y. Business: Cancer The institute joined the Worldwide Innovative Networking (WIN) Consortium. The consortium, which includes 29 academic institutions, biotech and …
Published on 2/18/2013
-
Novartis AG (NYSE:NVS; SIX:NOVN), Basel, Switzerland Business: Endocrine/Metabolic Novartis filed a complaint in a German court in December through which it is seeking to block an assessment of its dipeptidyl peptidase-…
Published on 2/18/2013
-
Par Pharmaceutical Cos. Inc. (NYSE:PRX), Woodcliff Lake, N.J. Sucampo Pharmaceuticals Inc. (NASDAQ:SCMP), Bethesda, Md. Takeda Pharmaceutical Co. Ltd. (Tokyo:4502), Osaka, Japan Business: Gastrointestinal Sucampo and …
Published on 2/18/2013
-
Phylogica Ltd. (ASX:PYC; Xetra:PH7), Subiaco, Australia Bio-Link Australia Pty. Ltd., Sydney, Australia Business: Inflammation, Pulmonary Phylogica engaged life sciences business development company Bio-Link to monetize…
Published on 2/18/2013
-
Somaxon Pharmaceuticals Inc. (NASDAQ:SOMX), San Diego, Calif. Actavis Inc. (NYSE:ACT), Parsippany, N.J. Business: Neurology Somaxon granted Actavis non-exclusive rights to sell a generic version of insomnia drug Silenor…
Published on 2/18/2013
-
Tranzyme Inc. (NASDAQ:TZYM), Durham, N.C. Business: Gastrointestinal Tranzyme's board said the company will explore strategic alternatives, including a possible merger, sale or other business transaction. Stifel is …
Published on 2/18/2013
-
Addex Therapeutics Ltd. (SIX:ADXN), Geneva, Switzerland Business: Autoimmune, Neurology Addex said it plans to reduce the size of its operations in Geneva and its early stage discovery efforts to focus its resources on …
Published on 2/11/2013
-
Allenex AB (SSE:ALNX), Stockholm, Sweden Business: Transplant, Diagnostic Allenex received 215,000 ($292,293) as part of a 2.6 million ($3.6 million) award from the EU's Seventh Framework Program (FP7) to the EUROSTAM …
Published on 2/11/2013
-
Allergan Inc. (NYSE:AGN), Irvine, Calif. Business: Endocrine/Metabolic Allergan said in its 4Q12 earnings that it plans to sell its obesity intervention business. The decision is the result of the company's review of …
Published on 2/11/2013
-
AntaBio, Labege, France The Wellcome Trust, London, U.K. Business: Infectious AntaBio received 4.7 million ($6.4 million) in Seeding Drug Discovery Initiative Funding from the Wellcome Trust to develop a small molecule …
Published on 2/11/2013
-
Boehringer Ingelheim GmbH, Ingelheim, Germany Business: Pharmaceuticals The U.S. District Court for the Northern District of Ohio approved a consent decree of permanent injunction restraining Boehringer's Ben Venue …
Published on 2/11/2013
-
ExpreS2ion Biotechnology ApS, Horsholm, Denmark Eberhard Karls Universitat Tubingen, Tubingen, Germany European Vaccine Initiative (EVI), Heidelberg, Germany Institute de Recherche pour la Developpement, Marseille, …
Published on 2/11/2013
-
GlaxoSmithKline plc (LSE:GSK; NYSE:GSK), London, U.K. Business: Pharmaceuticals GlaxoSmithKline CEO Andrew Witty said in the pharma's 2012 earnings that the pharma will restructure its European pharmaceuticals business …
Published on 2/11/2013